Form D · Private Equity Fund
Drug Royalty IV, L.P.
Toronto, A6 · CIK 0001756700
Offering snapshot reported Nov 14, 2018 · SEC filing
- Reported sold
- Yet to sell Indefinite offering
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 14, 2018 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity, Pooled investment fund
- Exemptions
- 06b, 3C, 3C.7
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-325733
Source: Form D, filed Nov 14, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| N/A Dri Capital, Inc. | Promoter |
| N/A Drug Royalty Iv Gp, Llc | Executive, Promoter |
| Behzad Khosrowshahi | Executive |
| Andrea Sotak | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
100 King Street West Suite 7250
Toronto, A6, M5X 1B1
Toronto, A6, M5X 1B1